The silent pandemic of antimicrobial resistance: a one health systems approach

Antimicrobial resistance (AMR) has emerged as a critical global health challenge, threatening the effective treatment of infectious diseases across human, animal, and environmental systems and reflecting the interconnected nature of the One Health framework. Current estimates indicate that AMR caused approximately 1.27 million deaths in 2019, with projections suggesting it could lead to up to 10 million deaths annually by 2050 if left unaddressed. This review synthesizes evidence on the major molecular mechanisms driving resistance, including enzymatic inactivation of antibiotics, target site modification, efflux pump activity, and horizontal gene transfer mediated by mobile genetic elements. It further examines the growing resistance to critically important and last-resort antibiotics such as cephalosporins, fluoroquinolones, and colistin, highlighting the role of antimicrobial use in livestock, aquaculture, and clinical settings in accelerating resistance. Environmental reservoirs, including pharmaceutical effluents, wastewater systems, and agricultural runoff, are identified as key contributors to the persistence and dissemination of antimicrobial resistance genes. The review also evaluates global surveillance systems and antimicrobial stewardship programs, while emphasizing persistent gaps in low- and middle-income countries due to limited infrastructure, regulation, and awareness. Socioeconomic factors, inadequate sanitation, and unregulated antibiotic use further compound the burden of AMR, while the declining pipeline of new antimicrobials underscores the urgency for innovation. Addressing AMR requires coordinated global action through strengthened stewardship, integrated surveillance, regulatory reforms, environmental management, and investment in research, guided by a comprehensive One Health approach. Without immediate and sustained intervention, AMR is poised to undermine decades of medical progress and become a leading cause of mortality worldwide.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-02
DOI
https://doi.org/10.5281/zenodo.19974010
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The silent pandemic of antimicrobial resistance: a one health systems approach

Vilis D. Patel, Rafiyuddin. A. Mathakiya, Charmi M. Patel
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical and Antibiotic Environmental Impacts
article

The silent pandemic of antimicrobial resistance: a one health systems approach

Vilis D. Patel, Rafiyuddin. A. Mathakiya, Charmi M. Patel
article en

Abstract

Antimicrobial resistance (AMR) has emerged as a critical global health challenge, threatening the effective treatment of infectious diseases across human, animal, and environmental systems and reflecting the interconnected nature of the One Health framework. Current estimates indicate that AMR caused approximately 1.27 million deaths in 2019, with projections suggesting it could lead to up to 10 million deaths annually by 2050 if left unaddressed. This review synthesizes evidence on the major molecular mechanisms driving resistance, including enzymatic inactivation of antibiotics, target site modification, efflux pump activity, and horizontal gene transfer mediated by mobile genetic elements. It further examines the growing resistance to critically important and last-resort antibiotics such as cephalosporins, fluoroquinolones, and colistin, highlighting the role of antimicrobial use in livestock, aquaculture, and clinical settings in accelerating resistance. Environmental reservoirs, including pharmaceutical effluents, wastewater systems, and agricultural runoff, are identified as key contributors to the persistence and dissemination of antimicrobial resistance genes. The review also evaluates global surveillance systems and antimicrobial stewardship programs, while emphasizing persistent gaps in low- and middle-income countries due to limited infrastructure, regulation, and awareness. Socioeconomic factors, inadequate sanitation, and unregulated antibiotic use further compound the burden of AMR, while the declining pipeline of new antimicrobials underscores the urgency for innovation. Addressing AMR requires coordinated global action through strengthened stewardship, integrated surveillance, regulatory reforms, environmental management, and investment in research, guided by a comprehensive One Health approach. Without immediate and sustained intervention, AMR is poised to undermine decades of medical progress and become a leading cause of mortality worldwide.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 10%
Pharmaceutical and Antibiotic Environmental Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The silent pandemic of antimicrobial resistance: a one health systems approach — Vilis D. Patel, Rafiyuddin. A. Mathakiya, Charmi M. Patel · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS